Radiation-Preserving Selective Imaging for Pediatric Hip Dysplasia: A Cross-Modal Ultrasound-Xray Policy with Limited Labels
This work addresses radiation exposure in pediatric patients with developmental dysplasia of the hip, though it is incremental as it builds on existing methods with limited labels.
The paper tackled the problem of reducing unnecessary radiation exposure in pediatric hip dysplasia diagnosis by developing an ultrasound-first policy that selectively requests X-rays only when needed, achieving measurement errors such as alpha MAE of ~9.7 degrees and AI MAE of ~7.6 degrees.
We study an ultrasound-first, radiation-preserving policy for developmental dysplasia of the hip (DDH) that requests a radiograph only when needed. We (i) pretrain modality-specific encoders (ResNet-18) with SimSiam on a large unlabelled registry (37186 ultrasound; 19546 radiographs), (ii) freeze the backbones and fit small, measurement-faithful heads on DDH-relevant landmarks and measurements, (iii) calibrate a one-sided conformal deferral rule on ultrasound predictions that provides finite sample marginal coverage guarantees under exchangeability, using a held-out calibration set. Ultrasound heads predict Graf alpha, beta, and femoral head coverage; X-ray heads predict acetabular index (AI), center-edge (CE) angle and IHDI grade. On our held out labeled evaluation set, ultrasound measurement error is modest (e.g., alpha MAE ~= 9.7 degrees, coverage MAE ~= 14.0%), while radiographic probes achieve AI and CE MAEs of ~= 7.6 degrees and ~= 8.9 degrees, respectively. The calibrated US-only policy is explored across rule families (alpha-only; alpha OR coverage; alpha AND coverage), conformal miscoverage levels, and per-utility trade-offs using decision-curve analysis. Conservative settings yield high coverage with near-zero US-only rates; permissive settings (e.g., alpha OR coverage at larger deltas) achieve non-zero US-only throughput with expected coverage tradeoffs. The result is a simple, reproducible pipeline that turns limited labels into interpretable measurements and tunable selective imaging curves suitable for clinical handoff and future external validation.